InspireMD to Participate at the Investor Summit Conference and Present to Investors on May 17, 2021

InspireMD, Inc. (NYSE American: NSPR) developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), announced today that management will participate at the Investor Summit Conference on May 17, 2021.

Chief Executive Officer Marvin Slosman will deliver his corporate presentation at 11:00am ET on May 17, 2021.

Investors can also request a one-on-one meeting with Mr. Slosman to be arranged following the conclusion of the conference.